Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Dunner

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
Journal of Psychiatric Practice|January 9, 2020
Repetitive Transcranial Magnetic Stimulation in the Treatment of Bipolar Depression: Experience From a Clinical SettingAngela L Phillips, Robert L Burr, David L Dunner
Journal of Affective Disorders|August 27, 2018
rTMS effects in patients with co-morbid somatic pain and depressive mood disordersAngela L Phillips, Robert L Burr, David L Dunner
Bipolar Disorders|March 12, 2008
Rapid cycling bipolar disorder--diagnostic conceptsMichael Bauer, Serge Beaulieu, David L Dunner, et al.
Clinical Therapeutics|March 2, 2006
Efficacy and tolerability of controlled-release paroxetine in the treatment of severe depression: post hoc analysis of pooled data from a subset of subjects in four double-blind clinical trialsDavid L Dunner, Alan Lipschitz, Cornelius D Pitts, et al.
Journal of Medical Economics|September 8, 2012
Medicare patient experience with vagus nerve stimulation for treatment-resistant depressionRachel L Feldman, David L Dunner, James S Muller, et al.
Convulsive Therapy|January 1, 1987
Treatment Options in Severe Psychotic DepressionArifulla Khan, Seth Cohen, Michelle Stowell, et al.
Depression and Anxiety|September 10, 2003
Duloxetine in treatment of anxiety symptoms associated with depressionDavid L Dunner, David J Goldstein, Craig Mallinckrodt, et al.
Journal of Affective Disorders|April 2, 2008
Psychotic symptoms in patients with bipolar maniaCarla M Canuso, Cynthia A Bossie, Young Zhu, et al.
The Journal of Clinical Psychiatry|August 10, 2007
Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot studyDavid L Dunner, Jay D Amsterdam, Richard C Shelton, et al.
Current Therapeutic Research, Clinical and Experimental|March 29, 2014
Clinical consequences of initial duloxetine dosing strategies: Comparison of 30 and 60 mg QD starting dosesDavid L Dunner, Madelaine M Wohlreich, Craig H Mallinckrodt, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
Journal of Psychiatric Practice|January 9, 2020
Repetitive Transcranial Magnetic Stimulation in the Treatment of Bipolar Depression: Experience From a Clinical SettingAngela L Phillips, Robert L Burr, David L Dunner
Journal of Affective Disorders|August 27, 2018
rTMS effects in patients with co-morbid somatic pain and depressive mood disordersAngela L Phillips, Robert L Burr, David L Dunner
Bipolar Disorders|March 12, 2008
Rapid cycling bipolar disorder--diagnostic conceptsMichael Bauer, Serge Beaulieu, David L Dunner, et al.
Clinical Therapeutics|March 2, 2006
Efficacy and tolerability of controlled-release paroxetine in the treatment of severe depression: post hoc analysis of pooled data from a subset of subjects in four double-blind clinical trialsDavid L Dunner, Alan Lipschitz, Cornelius D Pitts, et al.
Journal of Medical Economics|September 8, 2012
Medicare patient experience with vagus nerve stimulation for treatment-resistant depressionRachel L Feldman, David L Dunner, James S Muller, et al.
Convulsive Therapy|January 1, 1987
Treatment Options in Severe Psychotic DepressionArifulla Khan, Seth Cohen, Michelle Stowell, et al.
Depression and Anxiety|September 10, 2003
Duloxetine in treatment of anxiety symptoms associated with depressionDavid L Dunner, David J Goldstein, Craig Mallinckrodt, et al.
Journal of Affective Disorders|April 2, 2008
Psychotic symptoms in patients with bipolar maniaCarla M Canuso, Cynthia A Bossie, Young Zhu, et al.
The Journal of Clinical Psychiatry|August 10, 2007
Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot studyDavid L Dunner, Jay D Amsterdam, Richard C Shelton, et al.
Current Therapeutic Research, Clinical and Experimental|March 29, 2014
Clinical consequences of initial duloxetine dosing strategies: Comparison of 30 and 60 mg QD starting dosesDavid L Dunner, Madelaine M Wohlreich, Craig H Mallinckrodt, et al.
Pageof 11